+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05221372

Study of Blood Sampling in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors to Monitor Mutations and Drug Levels

Led by Erasmus Medical Center · Updated on 2022-02-18

1300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adults with non-small cell lung cancer who are being treated with tyrosine kinase inhibitors TKI. The goal is to collect repeated blood samples to test for mutations and analyze how the drug is processed in the body. This observational study aims to better understand the presence of cancer mutations and drug levels during treatment and disease progression. Blood samples will be taken ideally before starting TKI therapy, then at weeks 4, 8, 12, and every 4 to 8 weeks following local care guidelines. If patients switch TKIs, blood collection continues under a new study number. Sampling is done during steady-state periods before the next dose, with the morning dose postponed until after blood withdrawal. When disease progresses, if a biopsy is performed as standard care, extra blood and biopsy samples will be collected for detailed molecular analysis. Participants will have blood drawn during routine care visits, with additional samples stored for advanced testing. Biopsy samples will be split for standard and fresh frozen storage to allow RNA and other molecular studies. Researchers will track mutation levels in plasma, drug concentrations, time to progression or death, overall survival, and correlations with biopsy results, body mass index, and smoking status. The study lasts up to 10 years, with assessments aligned to clinical care and no interference with treatment decisions.

CONDITIONS

Brief Title

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)

Research Team

A

Anne-Marie Dingemans, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here